Vicore Pharma Holding AB (publ) (STO:VICO)

DFS Revenue

Vicore Pharma Holding AB had revenue of 892.00K SEK in the quarter ending March 31, 2025, a decrease of -99.14%. This brings the company's revenue in the last twelve months to 6.00M, down -94.25% year-over-year. In the year 2024, Vicore Pharma Holding AB had annual revenue of 109.35M.

• Revenue (ttm): 6.00M
• Revenue Growth: -94.25%
• P/S Ratio: 347.12
• Revenue / Employee: 181.67K
• Employees: 29
• Market Cap: 2.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	109.35M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-